Radiation Treatment Of Prostate Cancer

Radiation Treatment Of Prostate Cancer.
Smoking doubles the chances that a prostate cancer tireless will perceive his ailment spread and that he will eventually die from his illness, a new turn over finds. "Basically we found that people who smoke had a higher risk of their tumor coming back, of it spreading and, ultimately, even at death's door of prostate cancer," said look co-author Dr Michael Zelefsky. He is sin chair of clinical research in the sphere of radiation oncology at Memorial Sloan Kettering Cancer Center in New York City effect. "But interestingly, this applied only to 'current smokers' who were smoking around the term they received extrinsic smile radiantly therapy," Zelefsky added, referring to the standard form of emission treatment for prostate cancer.

So "Former smokers did not have the increased jeopardize for disease spread and recurrence that current smokers did. "However, we also looked at how smoking stiff treatment side effects," from the emanation treatment, which can include rectal bleeding and/or recurring and urgent urination article source. "And we saw that both patients who smoked and past smokers seemed to have a higher risk of urinary-related haughtiness effects after therapy".

Zelefsky and his colleagues reported the findings online Jan 27, 2015 in the paper BJU International. The enquiry team pointed out that 19 percent of American adults smoke. To look into the impact of smoking retailing on prostate cancer treatment and progression, the study authors focused on nearly 2400 patients who underwent therapy for prostate cancer between 1988 and 2005. Nearly 50 percent were identified as "former smokers," even if they had only kicked their costume brusquely before beginning cancer treatment.

Disease progression, relapse, symptoms and deaths were all tracked for an general of eight years, as were all reactions to the diffusion treatment. The researchers purposeful that the likelihood of surviving prostate cancer for a decade without experiencing any complaint recurrence was about 66 percent among patients who had never smoked. By comparison, that figure on fell to 52 percent amidst patients who were current smokers.

Complex Diagnostic Of Prostate Cancer

Complex Diagnostic Of Prostate Cancer.
Prostate biopsies that merge MRI technology with ultrasound appear to give men better poop with regard to the seriousness of their cancer, a new study suggests. The further technology - which uses MRI scans to cure doctors biopsy very specific portions of the prostate - diagnosed 30 percent more high-risk cancers than established prostate biopsies in men suspected of prostate cancer, researchers reported bazouka cream. These MRI-targeted biopsies also were better at weeding out low-risk prostate cancers that would not outrun to a man's death, diagnosing 17 percent fewer low-grade tumors than principle biopsy, said major father Dr Peter Pinto.

He is principal of the prostate cancer sector at the US National Cancer Institute's Center for Cancer Research in Bethesda, MD. These results evidence that MRI-targeted biopsy is "a better fashion of biopsy that finds the assertive tumors that need to be treated but also not finding those poor microscopic low-grade tumors that are not clinically important but lead to overtreatment" find out more. Findings from the sanctum are published in the Jan 27, 2015 Journal of the American Medical Association.

Doctors performing a habitual biopsy use ultrasound to superintend needles into a man's prostate gland, on average taking 12 core samples from predetermined sections. The difficult is, this type of biopsy can be inaccurate, said swot lead author Dr Mohummad Minhaj Siddiqui, an underling professor of surgery at the University of Maryland School of Medicine and vice-president of urologic robotic surgery at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore.

And "Occasionally you may about the cancer or you may dekko the cancer, just get an edge of it, and then you don't recall the full extent of the problem". In a targeted biopsy, MRIs of the suspected cancer are fused with real-time ultrasound images, creating a map of the prostate that enables doctors to pinpoint and trial uneasy areas. Prostate cancer testing has become quite disputable in recent years, with medical experts debating whether too many men are being diagnosed and treated for tumors that would not have led to their deaths.

Removal of the prostate gland can cause bad inconsequential effects, including impotence and incontinence, according to the US National Cancer Institute. But, even if a tumor isn't life-threatening, it can be psychologically intractable not to pay for the tumor. To try the effectiveness of MRI-targeted biopsy, researchers examined just over 1000 men who were suspected of prostate cancer because of an queer blood screening or rectal exam.

Slowly Progressive Prostate Cancer Need To Be Watched Instead Of Treatment

Slowly Progressive Prostate Cancer Need To Be Watched Instead Of Treatment.
For patients with prostate cancer that has a down gamble of progression, energetic surveillance, also known as "watchful waiting," may be a becoming treatment option, according to a large-scale ponder from Sweden. The issue of how (or whether) to pay for localized prostate cancer is controversial because, especially for older men, the tumor may not go far enough to cause real trouble during their unconsumed expected lifespan proextenderworld.com. In those cases, deferring treatment until there are signs of cancer progression may be the better option.

The researchers looked at almost 6900 patients from the National Prostate Cancer Registry Sweden, length of existence 70 or younger, who had localized prostate cancer and a blue or intermediary risk that the cancer would progress gratis. From 1997 through December 2002, over 2000 patients were assigned to occupied surveillance, alongside to 3400 underwent radical prostatectomy (removal of the prostate and some abutting tissue), and more than 1400 received radiation therapy.

Weather Conditions May Affect Prostate Cancer Patients

Weather Conditions May Affect Prostate Cancer Patients.
A late swot links dry, dismal weather to higher rates of prostate cancer. While the findings don't sustain a direct link, researchers guess that weather may affect pollution and, in turn, boost prostate cancer rates noflam for sale. "We found that colder weather, and short rainfall, were strongly correlated with prostate cancer," researcher Sophie St-Hilaire, of Idaho State University, said in a tidings release.

So "Although we can't communicate just why this correlation exists, the trends are in keeping with what we would expect given the effects of climate on the deposition, absorption, and discredit of persistent organic pollutants including pesticides" vigrx plus pills side effects. St-Hilaire and colleagues premeditated prostate cancer rates in counties in the United States and looked for links to shire weather patterns.

They found a link, and suggest it may persist because cold weather slows the degradation of pollutants. Prostate cancer will affect about one in six men, according to training information in the study. Reports suggest it's more common in the northern hemisphere.

Statins May Reduce The Risk Of Prostate Cancer

Statins May Reduce The Risk Of Prostate Cancer.
Cholesterol-lowering statins significantly degrade prostate tumor inflammation, which may relief let the risk of disease progression, redone study findings suggest startvigrx top. Duke University Medical Center researchers found that the use of statins before prostate cancer surgery was associated with a 69 percent reduced good chance of irritation by nature prostate tumors.

For the study, the researchers examined tissue samples of prostate tumors from 236 men undergoing prostate cancer surgery endora m se breast size bdta hai kya. The patients included 37 who took statins during the year old to their surgery.

Overall, 82 percent of the men had explosive cells in their prostate tumors and about one-third had conspicuous tumor inflammation. After they accounted for factors such as age, blood and body-mass hint (a height that is based on weight and height), the Duke rig concluded that statin use was associated with reduced redness within tumors.

In Men With Prostate Cancer Observed Decrease In Penis Size

In Men With Prostate Cancer Observed Decrease In Penis Size.
A stinting reckon of men with prostate cancer gripe that their penis appears to be shorter following treatment, doctors report. According to researchers from the Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, these patients said that this unexpected haughtiness purport interfered with their imply relationships and made them weep the type of treatment they had chosen buy pure dmma turkey. "Prostate cancer is one of the few cancers where patients have a well-chosen of therapies, and because of the gamut of possible side effects, it can be a tough choice," contemplate leader Dr Paul Nguyen, a radiation oncologist, said in a Dana-Farber gossip release.

So "This study says that when penile shortening does occur, it exceedingly does affect patients and their dignity of life. It's something we should be discussing up front so that it will help rub treatment regrets". The side effect was most common amid men who had prostatectomies, which is the surgical removal of the prostate, and those who had hormone-based treatment coupled with radiation medicine. Nguyen added that most patients are able to survive with just about any side effect if they know about it in advance.

The study involved 948 men with incessant prostate cancer. The men were enrolled in a registry that collects gen on patients whose prostate cancer shows signs of coming back after their first place treatment. Most of the men were between the ages of 60 and 80. Of the men confusing in the study, 54 percent had their prostate surgically removed, 24 percent received emanation combined with hormone-blocking therapy and 22 percent chose to stand only radiation.

Effect Of Anesthesia In Surgery Of Prostate Cancer

Effect Of Anesthesia In Surgery Of Prostate Cancer.
For men having prostate cancer surgery, the genre of anesthesia doctors use might traverse a unlikeness in the inequality of the cancer returning, a new study suggests. Researchers found that of nearly 3300 men who underwent prostate cancer surgery, those who were given both assorted and regional anesthesia had a soften risk of seeing their cancer development than men who received only general anesthesia provillus scriptovore.com. Over a term of 15 years, about 5 percent of men given only general anesthesia had their cancer again in their bones or other sites, the researchers said.

That compared with 3 percent of men who also received regional anesthesia, which typically meant a spinal injection of the palliative morphine, with an increment of a numbing agent. None of that, however, proves that anesthesia choices as soon as stir a prostate cancer patient's prognosis vibracon smoke alarm monitor v1 manual. "We can't conclude from this that it's cause-and-effect," said chief researcher Dr Juraj Sprung, an anesthesiologist at the Mayo Clinic in Rochester, Minn.

But one theory is that spinal painkillers - opposite number the opioid morphine - can present a variation because they bridle patients' need for opioid drugs after surgery. Those post-surgery opioids, which influence the whole body, may curtailment the immune system's effectiveness. That's potentially important because during prostate cancer surgery, some cancer cells mainly cut out into the bloodstream - and a fully functioning immune response might be needed to assassinate them off. "If you avoid opioids after surgery, you may be increasing your cleverness to fight off these cancer cells.

The study, reported online Dec 17, 2013 in the British Journal of Anaesthesia, is not the essential to ponder a link between regional anesthesia and a lower chance of cancer recurrence or progression. Some past studies have seen a equivalent pattern in patients having surgery for breast, ovarian or colon cancer. But those studies, appreciate the current one, headland only to a correlation, not a cause-and-effect link. Dr David Samadi, supervisor of urology at Lenox Hill Hospital in New York City, agreed.

Smoking And Weight Gain Increases The Death Rate From Prostate Cancer

Smoking And Weight Gain Increases The Death Rate From Prostate Cancer.
Men treated for prostate cancer who smoke or put on leftover pounds increase their discrepancy of illness recurrence and of dying from the illness, two recent studies show thyromine.herbalyzer.com. The findings were presented Tuesday at the American Association for Cancer Research's annual converging in Washington, DC.

In the in the first place report, a team led by Dr Jing Ma, an ally professor of medicine at Brigham and Women's Hospital in Boston, found that size and smoking may not be risk factors for developing prostate cancer, but they do expand the odds that a man who has the illness will pay the debt of nature from it startvigrx.com. Being heavy and smoking "predispose men to a significantly drunk risk of cancer-specific and all-cause mortality," Ma said during a Tuesday forenoon news conference.

"Compared to lean non-smokers, pot-bellied smokers had the highest risk of prostate cancer mortality". For the study, Ma's yoke collected data on more than 2700 men with prostate cancer who took responsibility in the Physicians Health Study. Over 27 years of follow-up, 882 of the men died, 11 percent from the cancer.

The researchers found that both impact farther away and smoking boosted the chance for dying from the cancer. In fact, every five-point snowball in body mass index (BMI) increased the imperil for dying from prostate cancer by 52 percent. BMI is a capacity of height versus weight, with the threshold of overweight set at a BMI of 25 and the entrance for obesity set at a BMI of 30.

In addition, men who smoked increased their jeopardize for dying from the cancer by 55 percent, compared with men who never smoked, the learning found. "These facts underscore the need for implementing effective hindering strategies for weight control and reducing tobacco use in both robust men as well as prostate cancer patients".

In a second report, a duo led by Corinne E Joshu, a postdoctoral fellow in the bailiwick of epidemiology at Johns Hopkins Bloomberg School of Public Health, found that men who gained power after having their prostate removed were almost twice as apposite to see their cancer return as were men who maintained their weight. "Weight enhancement may increase the risk of prostate cancer recurrence after prostatectomy," Joshu said during the AACR scuttlebutt conference.

"Obesity, especially to each inactive men, may also contribute to the risk of prostate cancer recurrence". For the study, Joshu's party confident data on more than 1300 men with localized prostate cancer who underwent prostatectomy between 1993 and 2006. In addition, the men completed a get a bird's eye view of on diet, lifestyle and other factors such as weight, level and tangible activity five years before surgery and again one year after the procedure.

Rapid Diagnostics Of Cancer Increases The Number Of Cases Overdiagnosis

Rapid Diagnostics Of Cancer Increases The Number Of Cases Overdiagnosis.
A untrained over again suggests that doctors needfulness to address the problem of overdiagnosis in cancer dolour - the detection and possible treatment of tumors that may never cause symptoms or outdo to death medicine. The review authors found that about 25 percent of teat cancers found through mammograms and about 60 percent of prostate cancers detected through prostate-specific antigen (PSA) tests may be examples of overdiagnosis.

About half of lung cancers detected through some screening tests may also embody overdiagnosis get real hgh. For several types of cancer - thyroid, prostate, breast, kidney and melanoma - the numeral of additional cases has gone up over the background 30 years, but the extirpation have a claim to has not, the authors noted.

Research suggests that more screening tests are chief for the increased diagnosis rate. "Whereas beforehand detection may well help some, it undoubtedly hurts others," Dr H Gilbert Welch and Dr William Black, of the VA Medical Center in White River Junction, Vt, and the Dartmouth-Hitchcock Medical Center, wrote in a hearsay let off from the US National Cancer Institute.

So "Often the steadfastness about whether or not to on beginning cancer detection involves a delicate balance between benefits and harms - contrastive individuals, even in the same situation, might reasonably mutate different choices". In a commentary, Dr Laura Esserman, of the University of California at San Francisco, and Dr Ian Thompson, of the University of Texas Health Science Center at San Antonio, wrote: "What we basic now in the entrants of cancer is the coming together of physicians and scientists of all disciplines to crop the weigh down of cancer obliteration and cancer diagnosis.

An Approved Vaccine To Treat Prostate Cancer Has Few Side Effects

An Approved Vaccine To Treat Prostate Cancer Has Few Side Effects.
The newly approved restorative prostate cancer vaccine, Provenge, is satisfactory and has few squad effects, a fresh study finds. In April, the US Food and Drug Administration approved the vaccine for use in men with advanced prostate cancer who had failed hormone therapy online. "Provenge was approved based on both cover and clinical data," said captain researcher Dr Simon J Hall, bench of urology at Mount Sinai Medical Center in New York City.

This refuge information shows that there are very little philosophy effects. The advantage of the vaccine for patients with metastatic hormone-resistant prostate cancer is that it has fewer standpoint crap than chemotherapy, which is the only other treatment option for these patients stretch mark removal costs. In addition, Provenge has improved survival over chemotherapy.

The so so survival time for men given Provenge is 4,5 months, although some patients gnome their lives extended by two to three years. "This is a newly at one's disposal treatment, with very small side effects, compared to anything else that a mortals would be considering in this state". Hall was to present the results on Monday at the American Urological Association annual conclave in San Francisco.

Data from four condition 3 trials, which included 904 men randomized to either Provenge or placebo, showed the vaccine extended survival, improved supremacy of freshness and had only mild side effects. In fact, more than 83 percent of the men who received Provenge were able to do respond activities without any restrictions, the researchers noted.

New Ways Of Treating Prostate Cancer And Ovarian Cancer

New Ways Of Treating Prostate Cancer And Ovarian Cancer.
New experiment with supports untried ways to favour ovarian and prostate cancer, while producing a unfulfilment for those with a certain form of colon cancer. Both the ovarian and prostate cancer trials could modification clinical practice, with more women taking the treatment bevacizumab (Avastin) to combat the disease in its advanced stages and more men getting dispersal therapy for locally advanced prostate cancer, according to researchers who presented the findings Sunday at the American Society of Clinical Oncology (ASCO) annual intersection in Chicago vimax online in kuwait. A third trial, looking at the effectiveness of cetuximab (Erbitux) in treating inescapable colon cancer patients, found the hypnotic made teeny contrast to their survival.

The first study found that adding Avastin to law chemotherapy (carboplatin and paclitaxel) and continuing with "maintenance" Avastin after chemo truly slowed the time-to-disease recurrence in women with advanced ovarian cancer. Avastin is an anti-angiogenic drug, import it interferes with a tumor's blood supply herbala.xyz. "This is the gold molecular-targeted and key anti-angiogenesis therapy to demonstrate benefit in this citizens and, combined with chemotherapy followed by Avastin maintenance, should be considered as one regulative option for women with this disease," said lead researcher Dr Robert A Burger, number one of the Women's Cancer Center at Fox Chase Cancer Center in Philadelphia.

So "This is a renewed implied treatment paradigm for stage 3 and 4 ovarian cancer," added Dr Jennifer Obel, an attending doctor at Northshore University Health System and master of ceremonies of a Sunday newscast conference at which these results were presented. The status 3 study involved almost 1,900 women with condition 3 and stage 4 ovarian cancer. Those who received timber chemotherapy plus Avastin, and then maintenance Avastin, for up to 10 months lived just over 14 months without their plague progressing compared with about 10 months for those receiving gauge chemotherapy alone.

Those who received chemo addition Avastin but no maintenance downer lived without a recurrence for 11,3 months, a difference not considered statistically significant. "I'm cautiously bullish about this data. It distinctly shows that those who had maintenance Avastin had improved profession-free survival," said Dr Robert Morgan, co-director of the gynecologic oncology program at City of Hope Cancer Center in Duarte, Calif. "I expect we have to break for longer incumbency outcomes before we serve as definite conclusions. It's too early for overall survival aid data".

However, he pointed out, a four-month difference for progression-free survival is "substantial". Doctors are already using Avastin off-label thoroughly to wine and dine ovarian cancer although it is not yet approved for this use. It has been shown to be more active in this cancer than in many cancers for which it is approved.

A New Prostate Cancers Treatment Strategy

A New Prostate Cancers Treatment Strategy.
Conventional clear-sightedness has it that merry levels of testosterone help prostate cancers grow. However, a new, young exploration suggests that a treatment strategy called bipolar androgen cure - where patients alternate between low and high levels of testosterone - might deputize prostate tumors more responsive to rating hormonal therapy. As the researchers explained, the primary remedying for advanced prostate cancer is hormonal therapy, which lowers levels of testosterone to mitigate the tumor from growing vitomol.eu. But there's a problem: Prostate cancer cells inevitably subdue the psychotherapy by increasing their ability to suck up any remaining testosterone in the body.

The budding strategy forces the tumor to respond again to higher testosterone levels, serving to reverse its resistance to standard therapy, the researchers say worldplusmed.com. If confirmed in several continuous larger trials, "this could place to a new treatment approach" for prostate cancers that have grown unsubmissive to hormonal therapy, said lead researcher Dr Michael Schweizer, an underling professor of oncology at the University of Washington School of Medicine in Seattle.

So "It needs to be stressed that bipolar androgen treatment is not handy for adoption into formula clinical practice, since these studies have not been completed. The report was published Jan 7, 2015 in the register Science Translational Medicine. For the study, 16 men with hormone therapy-resistant prostate cancer received bipolar androgen therapy. Of these patients, seven had their cancer go into remission. In four men, tumors shrank, and in one man, tumors disappeared completely, the researchers report.

Smoking And Excess Weight Can Lead To A Cancer

Smoking And Excess Weight Can Lead To A Cancer.
Men with prostate cancer may support their survival chances if they supplant being fats and carbohydrates in their fare with healthy fats such as olive oils, nuts and avocados, experimental research suggests June 2013. Men who substituted 10 percent of their ordinary calories from animal fats and carbs with such nourishing fats as olive oil, canola oil, nuts, seeds and avocados were 29 percent less odds-on to be no more from spreading prostate cancer and 26 percent less able to die from any other disease when compared to men who did not make this healthy swap, the read found fav-store. And a little bit seems to go a hunger way.

Specifically, adding just one daily tablespoon of an oil-based salad dressing resulted in a 29 percent demean risk of at death's door from prostate cancer and a 13 percent lower risk of slipping away from any other cause, the study contended. In the study, nearly 4600 men who had localized or non-spreading prostate cancer were followed for more than eight years, on average 4 rx box. During the study, 1064 men died.

Of these, 31 percent died from hub disease, slight more than 21 percent died as a end of prostate cancer and minor extent less than 21 percent died as a consequence of another type of cancer. The findings appeared online June 10 in JAMA Internal Medicine. The den can't break for certain that including healthy fats in the diet was responsible for the survival sharpness seen among men.

New Blood Test Can Detect Prostate Cancer More Accurately And Earlier

New Blood Test Can Detect Prostate Cancer More Accurately And Earlier.
A late blood check-up to area a cluster of specific proteins may show the presence of prostate cancer more accurately and earlier than is now possible, brand-new research suggests. The test, which has thus far only been assessed in a guide study, is 90 percent accurate and returned fewer false-positive results than the prostate spelled out antigen (PSA) test, which is the widespread clinical standard, the researchers added scriptovore.com. Representatives of the British enterprise that developed the test, Oxford Gene Technology in Oxford, presented the findings Tuesday at the International Conference on Molecular Diagnostics in Cancer Therapeutic Development in Denver, hosted by the American Association for Cancer Research.

The investigation looks for auto-antibodies for cancer, comparable to the auto-antibodies associated with autoimmune diseases such as fount 1 diabetes, rheumatoid arthritis and lupus. "These are antibodies against our own proteins," explained John Anson, Oxford's failing president of biomarker discovery. "We're dispiriting to demeanour for antibodies generated in the prehistoric stages of cancer what is melaquin pm cream company. This is an exquisitely subtle means that we're exploring with this technology".

Such a evaluation generates some excitement not only because it could theoretically detect tumors earlier, when they are more treatable, but auto-antibodies can be "easily detected in blood serum. It's not an invasive technique. It's a mere blood test," Anson noted. The researchers came up with groups of up to 15 biomarkers that were mete out in prostate cancer samples and not propinquitous in men without prostate cancer. The prove also was able to contradistinguish actual prostate cancer from a more non-malignant condition.

Because a patent is currently pending, Anson would not lean the proteins included in the test. "We are going on to a much more exhaustive follow-on study. At the moment, we are captivating over 1,800 samples, which includes 1,200 controls with a well range of 'interfering diseases' that men of 50-plus are horizontal to and are running a very large analytical validation study," Anson said.

PSA Kinetics Is Not A Sufficient Indication For The Treatment Of Prostate Cancer

PSA Kinetics Is Not A Sufficient Indication For The Treatment Of Prostate Cancer.
A genius that urologists had hoped would manufacture it reachable to sense men with prostate cancer who need treatment from those who would only privation watchful waiting didn't work well, researchers report. The technique, called PSA kinetics, measures changes in the compute at which the prostate gland produces a protein called prostate-specific antigen medrxcheck. A significant enlarge in PSA kinetics, stately by the leisure during which PSA production doubles or increases at a lightning rate, is supposed to indicate the need for treatment, by radiation analysis or surgery.

PSA kinetics has long been used to measure the effectiveness of treatment buyrxworld.com. A count of cancer centers have started to use it as a practicable method of distinguishing aggressive cancers that require treatment from those that are so slow-growing that they can safely be sinistral alone.

Recent studies indicating that many men with slow-growing prostate cancers sustain unnecessary treatment have given emergency to the search for such a tool, especially considering that side effects of treatment can embrace incontinence and impotence. But the study indicates that "PSA kinetics doesn't seem to be enough to show you who you should follow and who you should treat," said Dr Ashley E Ross, a urology residing at the Johns Hopkins University Brady Urological Institute, and escort initiator of a report on the technique published online May 3 in the Journal of Clinical Oncology.

The come in describes the results of PSA kinetics measurements of 290 men with low-grade prostate cancer - the gracious that often doesn't command therapy - for an average of 2,9 years. The results of PSA tests were compared with biopsies - interweaving samples - that regular the progression of the cancers.

The essay is part of a study, under supervision of Dr H Ballentine Carter, leader of the division of adult urology at the Brady Urological Institute, that began in 1994. Men in the hardship had PSA tests every six months and biopsies every year.

Mass Screening For Prostate Cancer Can Have Unpleasant Consequences

Mass Screening For Prostate Cancer Can Have Unpleasant Consequences.
Health campaigns that highlight the refractory of glum screening rates for prostate cancer to support such screenings seem to have an unintended effect: They awe men from undergoing a prostate exam, a budding German study suggests howporstarsgrowit.com. The finding, reported in the present issue of Psychological Science, stems from effectuate by a research team from the University of Heidelberg that gauged the goal to get screened for prostate cancer among men over the discretion of 45 who reside in two German cities.

In earlier research, the inquiry authors had found that men who had never had such screenings tended to take it that most men hadn't either pulmonary. In the current effort, the side exposed men who had never been screened to one of two health low-down statements: either that only 18 percent of German men had been screened in the existence year, or that 65 percent of men had been screened.